These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1783973)

  • 21. Extruder scale-up assessment in the process of extrusion-spheronization: comparison of radial and axial systems by a design of experiments approach.
    Désiré A; Paillard B; Bougaret J; Baron M; Couarraze G
    Drug Dev Ind Pharm; 2013 Feb; 39(2):176-85. PubMed ID: 23216219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigations on the influence of the type of extruder for pelletization by extrusion-spheronization. I. Extrusion behavior of formulations.
    Thoma K; Ziegler I
    Drug Dev Ind Pharm; 1998 May; 24(5):401-11. PubMed ID: 9876602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation on drug dissolution and particle characteristics of pellets related to manufacturing process variables of high-shear granulation.
    Dévay A; Mayer K; Pál S; Antal I
    J Biochem Biophys Methods; 2006 Nov; 69(1-2):197-205. PubMed ID: 16650480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of process variables on physical properties of the pellets using extruder and spheronizer.
    Umprayn K; Chitropas P; Amarekajorn S
    Drug Dev Ind Pharm; 1999 Jan; 25(1):45-61. PubMed ID: 10028418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Masking of unpleasant gustatory sensation by cross-linking of dehydrated paracetamol alginate pellets produced by extrusion-spheronization.
    Kulkarni RB; Amin PD
    Drug Dev Ind Pharm; 2008 Feb; 34(2):199-205. PubMed ID: 18302039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of different variables on the in vitro dissolution of a theophylline sustained-release preparation].
    Fuchs WS; Jakobs R; Grunenberg P; Weiss G; Profitlich T; von Nieciecki A; Klemm FH; Laicher A; Stanislaus F
    Arzneimittelforschung; 1998 May; 48(5A):552-6. PubMed ID: 9676343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Theophylline loaded gastroretentive floating tablets based on hydrophilic polymers: preparation and in vitro evaluation.
    Khan F; Ibn Razzak SM; Khan ZR; Azad MA; Chowdhury JA; Reza S
    Pak J Pharm Sci; 2009 Apr; 22(2):155-61. PubMed ID: 19339225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving flow properties of ibuprofen by fluidized bed particle thin-coating.
    Ehlers H; Räikkönen H; Antikainen O; Heinämäki J; Yliruusi J
    Int J Pharm; 2009 Feb; 368(1-2):165-70. PubMed ID: 19010403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-scale characterization of wet powder masses suitable for extrusion-spheronization.
    Tuleu C; Chaumeil JC
    Drug Dev Ind Pharm; 1998 May; 24(5):423-9. PubMed ID: 9876604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneously Improving the Physicochemical Properties, Dissolution Performance, and Bioavailability of Apigenin and Daidzein by Co-Crystallization With Theophylline.
    Huang S; Xue Q; Xu J; Ruan S; Cai T
    J Pharm Sci; 2019 Sep; 108(9):2982-2993. PubMed ID: 31029571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo sustained-release characteristics of theophylline matrix tablets and novel cluster tablets.
    Hayashi T; Kanbe H; Okada M; Kawase I; Ikeda Y; Onuki Y; Kaneko T; Sonobe T
    Int J Pharm; 2007 Aug; 341(1-2):105-13. PubMed ID: 17512147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extrusion-spheronization manufacture of Gelucire matrix beads.
    Montoussé C; Pruvost M; Rodriguez F; Brossard C
    Drug Dev Ind Pharm; 1999 Jan; 25(1):75-80. PubMed ID: 10028421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline.
    Ammar HO; Ghorab M; El-nahhas SA; Omar SM; Ghorab MM
    Pharmazie; 1996 Jan; 51(1):42-6. PubMed ID: 8999434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled drug release from Gelucire-based matrix pellets: experiment and theory.
    Siepmann F; Muschert S; Flament MP; Leterme P; Gayot A; Siepmann J
    Int J Pharm; 2006 Jul; 317(2):136-43. PubMed ID: 16621362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC; Podczeck F; Turnbull N
    Int J Pharm; 2004 Nov; 285(1-2):51-63. PubMed ID: 15488679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of drug solubility and particle size on the pellet formulation in a rotoprocessor.
    Krejcová K; Rabisková M; Vetchý D; Polásek E; Tomásek V; Prokopová A
    Drug Dev Ind Pharm; 2006 Jun; 32(5):585-93. PubMed ID: 16720413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Optimization of liberation of theophylline derivatives from Gelucire matrix tablets].
    Ratsimbazafy V; Brossard C
    Pharm Acta Helv; 1992; 67(5-6):166-71. PubMed ID: 1438455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.